Stocks
Daiichi Sankyo Company, LimitedDSNKY
OTCHealthcarePharmaceuticals$17.64-3.24%
A Japan-based pharmaceutical company focused on developing and commercializing prescription medicines, with a strategic emphasis on oncology and antibody-drug conjugate (ADC) therapies. Its drug pipeline and partnerships—most notably with AstraZeneca on cancer treatments such as Enhertu—have made it...
Market Cap: $32.7B52W Range: $17.44 – $28.21
Congressional Interest in Daiichi Sankyo Company, Limited (DSNKY)
3 members of Congress have disclosed 3 trades in Daiichi Sankyo Company, Limited (DSNKY), a Healthcare company. The buy/sell breakdown shows 2 purchases versus 1 sale, indicating net buying interest from lawmakers. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
Total Disclosures
3
Unique Politicians
3
Buys
2
Sells
1
Who in Congress Is Trading DSNKY?
| Date | Politician | Type | Amount |
|---|---|---|---|
| 2024-07-01 | MICHAEL T. MCCAUL | buy | $1K – $15K |
| 2023-07-10 | Daniel Goldman | sell | $50K – $100K |